Individuals Coming Off Weight-Loss Jabs Gain Back Weight Far More Rapidly Than Those on Conventional Diets

New research indicates that people who come off blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover lost weight far faster than those who halt traditional lifestyle plans.

Published data in a leading medical journal shows that while overweight individuals can lose substantial amounts of their body weight while on the medication, the mass comes back at an average rate of nearly a kilo each month once they quit.

"People buying such drugs must be cognizant of the danger of fast weight regain when the therapy concludes," stated expert Dr. Susan Jebb.

Such speed of regain suggests a reversion to starting mass in about a year and a half.

Comparing Approaches

The analysis, which reviewed dozens of trials involving over 9,000 of participants, compared the results of these new drugs with older methods.

Scientists point out that people who shed pounds through dieting generally see a slower weight regain—around 100 grams monthly—after stopping.

The Reason for the Rapid Rebound

Nutrition scientists suggest the way of the injections explains the amplified rebound.

These medications imitate a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of GLP-1 concentrations far above than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.

"Stopping of this hormone supplement results in appetite is uncontrolled, making excessive eating much more probable."

A Chronic Disease?

The NHS recommend the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

A number of clinicians argue that, due to the high risk of relapse, the therapy should be considered life-long.

This opinion is echoed by drug manufacturers, who state that the results "emphasize the chronic nature of obesity," comparing it to managing conditions like diabetes.

Patient Accounts

Individuals who have discontinued the jabs describe a intense return of appetite.

"It was like something flipping and I was suddenly starving," said one woman.

This difficulty is exacerbated if individuals have not developed permanent dietary or behavioural changes during treatment.

Significant Adoption

Survey data indicate that millions of people in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.

• Adoption is greater among women compared to males.
• The 40s and 50s age group shows the highest level of interest.
• A large proportion access the medications through private healthcare rather than public health services.

Ultimately, clinicians caution that while GLP-1 drugs are powerful agents for shedding pounds, they are not a standalone fix and long-term success likely depends on ongoing behavioural support.